{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:20:06Z","timestamp":1787732406011,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000650","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ctro.2025.101060","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:40:55Z","timestamp":1760827255000},"page":"101060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcomes of pelvic and para-aortic stereotactic reirradiation for gynaecological cancer recurrence"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8836-0902","authenticated-orcid":false,"given":"Benjamin J","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kallol","family":"Bhadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Zing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-9139","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1147-3618","authenticated-orcid":false,"given":"Susan","family":"Lalondrelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.101060_b0005","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0010","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1470-2045(06)70903-2","article-title":"Pelvic exenteration for gynaecological tumours: achievements and unanswered questions","volume":"7","author":"H\u00f6ckel","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","article-title":"Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer","volume":"125","author":"Schmidt","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0020","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2023.02.010","article-title":"Clinical outcomes of pelvic exenteration for gynecologic malignancies","volume":"171","author":"Moolenaar","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0025","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European society for radiotherapy and oncology and european organisation for research and treatment of cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0030","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2025.101060_b0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0040","unstructured":"King\u2019s Technology Evaluation Centre. Commissioning through Evaluation: stereotactic ablative body radiotherapy (SABR) reirradiation report 2019."},{"key":"10.1016\/j.ctro.2025.101060_b0045","unstructured":"NHS England. Clinical Commissioning Policy: stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (all ages) 2021."},{"key":"10.1016\/j.ctro.2025.101060_b0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/153303460900800510","article-title":"Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies","volume":"8","author":"Kunos","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ctro.2025.101060_b0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/153303460800700504","article-title":"Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy","volume":"7","author":"Kunos","year":"2008","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ctro.2025.101060_b0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1748-717X-6-77","article-title":"Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results","volume":"6","author":"Dewas","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00249","article-title":"Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy","volume":"6","author":"Hasan","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0070","first-page":"5103","article-title":"Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a cooperative study of the korean radiation oncology group (KROG 14-11)","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ctro.2025.101060_b0075","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1111\/ajco.12185","article-title":"Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: Feasibility and complication","volume":"12","author":"Seo","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.prro.2019.05.012","article-title":"Salvage curative-intent reirradiation stereotactic body radiation therapy for isolated pelvic and\/or paraortic recurrences of gynecologic malignancies","volume":"9","author":"Ling","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0085","first-page":"415","article-title":"Stereotactic radiotherapy in recurrent gynecological cancer: a case series","volume":"22","author":"Deodato","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ctro.2025.101060_b0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijrobp.2008.07.020","article-title":"Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer","volume":"74","author":"Choi","year":"2009","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/IGC.0000000000000869","article-title":"Clinical outcomes for stereotactic ablativeradiotherapy in oligometastatic and oligoprogressivegynecological malignancies","volume":"27","author":"Mesko","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ctro.2025.101060_b0100","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamaoncol.2024.1796","article-title":"Stereotactic ablative radiotherapy for gynecological oligometastatic and oligoprogessive tumors","volume":"10","author":"Donovan","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2021.09.010","article-title":"An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation","volume":"164","author":"Slevin","year":"2021","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109947","article-title":"Re-irradiation in clinical practice: results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform","volume":"189","author":"Willmann","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13014-020-1469-8","article-title":"Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy","volume":"15","author":"Leung","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0125","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2025.101060_b0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2017.09.030","article-title":"Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): a systematic review","volume":"125","author":"Murray","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clon.2022.04.007","article-title":"Potential for isotoxic re-irradiation stereotactic ablative body radiotherapy in locally recurrent rectal cancer","volume":"34","author":"Robinson","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clon.2022.09.047","article-title":"Launch of the UK SABR consortium pelvic stereotactic ablative radiotherapy re-irradiation guidelines and national audit","volume":"35","author":"Muirhead","year":"2023","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.ctro.2025.101060_b0145","unstructured":"Andratschke N, Widder J, Willmann J. RECare (EORTC 2011-RP) Cohort. EORTC E2-Radiate n.d. https:\/\/project.eortc.org\/e2-radiate\/cohorts\/ (accessed July 16, 2025)."},{"key":"10.1016\/j.ctro.2025.101060_b0150","unstructured":"NHS Health Research Authority. DARIUS: Dose Accumulation in Re-Irradiation Using Science n.d. https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/darius-dose-accumulation-in-re-irradiation-using-science\/."},{"key":"10.1016\/j.ctro.2025.101060_b0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.brachy.2023.07.004","article-title":"Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers","volume":"22","author":"Mahantshetty","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2025.101060_b0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clon.2019.07.015","article-title":"Salvage re-irradiation with single-modality interstitial brachytherapy for the treatment of recurrent gynaecological tumours in the pelvis: a multi-institutional study","volume":"32","author":"Raziee","year":"2020","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2018.12.022","article-title":"Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer","volume":"152","author":"Ling","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ctro.2025.101060_b0170","article-title":"Clinical outcomes of intensity modulated proton therapy reirradiation for gynecologic malignancies","volume":"8","author":"Pollock","year":"2023","journal-title":"Adv Radiat Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:37:26Z","timestamp":1787729846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S2405630825001521"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101060","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of pelvic and para-aortic stereotactic reirradiation for gynaecological cancer recurrence","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101060"}}